Greenleaf Trust trimmed its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 5.6% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 59,029 shares of the company’s stock after selling 3,478 shares during the quarter. Greenleaf Trust’s holdings in Procter & Gamble were worth $8,576,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in PG. Mowery & Schoenfeld Wealth Management LLC bought a new stake in Procter & Gamble during the second quarter valued at about $26,000. Montgomery Financial Services LLC purchased a new position in Procter & Gamble during the 2nd quarter worth approximately $28,000. Paladin Partners LLC acquired a new stake in Procter & Gamble during the second quarter worth about $29,000. Evergreen Advisors LLC acquired a new position in Procter & Gamble in the first quarter valued at approximately $37,000. Finally, Toews Corp ADV acquired a new position in shares of Procter & Gamble in the 2nd quarter valued at $37,000. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Down 0.1%
Shares of NYSE PG opened at $161.42 on Monday. The stock has a market capitalization of $374.14 billion, a price-to-earnings ratio of 24.31, a price-to-earnings-growth ratio of 3.97 and a beta of 0.36. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $167.25. The firm has a 50-day moving average price of $149.99 and a 200 day moving average price of $148.94. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The company had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. During the same period last year, the firm earned $1.99 EPS. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. Equities research analysts anticipate that Procter & Gamble Company will post 6.99 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be given a $1.0885 dividend. The ex-dividend date is Friday, October 23rd. This represents a $4.35 annualized dividend and a yield of 2.7%. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.51%.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on PG shares. JPMorgan Chase & Co. lifted their target price on shares of Procter & Gamble from $162.00 to $180.00 and gave the stock an “overweight” rating in a research note on Friday, October 23rd. Argus cut Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Friday, August 7th. DZ Bank downgraded shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 27th. Morgan Stanley increased their price objective on Procter & Gamble from $166.00 to $185.00 and gave the company an “overweight” rating in a report on Friday, October 23rd. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Procter & Gamble in a research note on Friday, October 23rd. Fifteen analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $170.57.
Read Our Latest Research Report on PG
Insider Activity
In other news, insider Susan Whaley sold 2,369 shares of the business’s stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $344,310.46. Following the sale, the insider directly owned 30,730 shares in the company, valued at approximately $4,466,298.20. The trade was a 7.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Andre Schulten sold 3,914 shares of the business’s stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $568,860.76. Following the sale, the chief financial officer directly owned 65,618 shares in the company, valued at $9,536,920.12. The trade was a 5.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 58,647 shares of company stock valued at $9,268,508. 0.23% of the stock is currently owned by company insiders.
Trending Headlines about Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Analyst upgrade: Freedom Broker upgraded PG from “hold” to “buy,” providing a positive signal for the stock and reflecting greater confidence in the company’s outlook. Freedom Broker upgrades Procter & Gamble to buy from hold
- Positive Sentiment: Dividend appeal remains strong: Articles highlighted PG as a long-standing dividend leader, supporting its appeal to income-focused and defensive investors. The company’s record of dividend increases may help underpin demand for the shares, particularly when investors favor stable consumer-staples businesses. Dividend Kings article Trusted dividend stocks article
- Neutral Sentiment: Bond issuance adds balance-sheet context: PG’s euro- and dollar-denominated bond sale provides liquidity and funding flexibility, but it also draws attention to leverage, interest costs, and the company’s relatively elevated valuation. Procter & Gamble bond sale
- Neutral Sentiment: Growth story under review: Commentary on PG points to accelerating revenue growth, while also noting that higher operating costs could pressure margins and earnings. Investors are weighing improved sales momentum against cost inflation. Procter & Gamble revenue growth and costs What changed in Procter & Gamble’s story
- Negative Sentiment: Mixed rating signals and valuation risk: DZ Bank downgraded PG from “strong-buy” to “hold.” With shares trading at a premium valuation, a more cautious analyst stance could weigh on upside unless earnings growth accelerates. DZ Bank rating change
- Negative Sentiment: Advertising challenge produced only a limited win: Following PG’s challenge, the National Advertising Division supported Carpe’s $19.95 reference price but recommended changes or removal of other savings, free-shipping, comparative-performance, and “first” 100-hour protection claims. The outcome may modestly strengthen competitive advertising standards, but it does not represent a material financial catalyst for PG. National Advertising Division decision involving Carpe
Procter & Gamble Company Profile
Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
